The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation

Immunity

Volumn 9, Issue 3, 1998, Pages 377-383

  Mosyak, Lidia ^a   Zaller, Dennis M ^b   Wiley, Don C ^a  

^a HARVARD UNIVERSITY   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; HLA DM ANTIGEN; HLA DR1 ANTIGEN; HLA DR4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRYPTOPHAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; BINDING SITE; CATALYST; CONTROLLED STUDY; CRYSTAL STRUCTURE; DROSOPHILA; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; X RAY CRYSTALLOGRAPHY;

EID: 0032168861     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80620-2     Document Type: Article

References (52)

1. Beckman, E.M., Porcelli, S.A., Morita, C.T., Behar, S.M., Furlong, S.T., and Brenner, M.B. (1994). Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature 372, 691-694.
2. Brown, J.H., Jardetzky, T.S., Gorga, J.C., Stern, L.J., Urban, R.G., Strominger, J.L., and Wiley, D.C. (1993). The three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 368, 33-39.
3. Brünger, A.T. (1992). X-PLOR (Version 3.1): A System for X-Ray Crystallography and NMR. (New Haven, CT: Yale University Press).
4. Brünger, A.T., and Krukowski, A. (1990). Slow-cooling protocols for crystallographic refinement by simulated annealing. Acta Cryst. A 46, 585-593.
5. Burmeister, W.P., Gastinel, L.N., Simister, N.E., Slum, M.L., and Bjorkman, P.J. (1994). Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor. Nature 372, 336-343.
6. Busch, R., and Mellins, E.D. (1996). Developing and shedding inhibitions: how MHC class II molecules reach maturity. Curr. Opin. Immunol. 8, 51-58.
7. Busch, R., Doebele, R.C., von Scheven, E., Fahrni, J., and Mellins, E.D. (1998a). Abberrant intermolecular disulfide bonding in a mutant HLA-DM molecule: implications for assembly, maturation, and function. J. Immunol. 160, 734-743.
8. Busch, R., Reich, Z., Zaller, D., Sloan, V., and Mellins, E.D. (1998b). Secondary structure composition and pH-dependent conformational changes of soluble recombinant HLA-DM. J. Biol. Chem., in press.
9. Buus, S., Sette, A., and Grey, H.M. (1987). The interaction between protein-derived immunogenic peptides and Ia. Immunol. Rev. 98, 115-141.
10. Buus, S., Sette, A., Colon, S.M., and Grey, H.M. (1988). Autologous peptides constitutively occupy the antigen binding site on Ia. Science 242, 1045-1047.
11. Cho, S., Attaya, M., and Monaco, J.J. (1991). New class II-like genes in the murine MHC. Nature 353, 573-576.
12. Collaborative Computational Project, N. (1994). The CCP4 suite: Programs for protein crystallography. Acta Cryst. D 50, 760-763.
13. Cresswell, P. (1994). Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12, 259-293.
14. Cresswell, P. (1996). Invariant chain structure and MHC class II function. Cell 84, 505-507.
15. Denzin, L.K., and Cresswell, P. (1995). HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82, 155-165.
16. Denzin, L.K., Hammond, C., and Cresswell, P. (1996). HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med. 184, 2153-2165.
17. Denzin, L.K., Sant'Angelo, D.B., Hammond, C., Surman, M.J., and Cresswell, P. (1997). Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science 278, 106-109.
18. Dessen, A., Lawrence, C.M., Cupo, S., Zaller, D.M., and Wiley, D.C. (1997). X-ray crystal structure of HLA-DR4 (DRA1*0101, DRB1 *0401) complexed with a peptide from human collagen II. Immunity 7, 473-481.
19. Douek, D.C., and Altmann, D.M. (1997). HLA-DO is an intracellular class II molecule with distinctive thymic expression. Int. Immunol. 9, 355-364.
20. Fing, S.P., Arp, B., and Pious, D. (1994). HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 368, 554-558.
21. Fremont, D.H., Hendrickson, W.A., Marrack, P., and Kappler, J. (1996). Structures of an MHC class II molecule with covalently bound single peptides. Science 272, 1001-1004.
22. Germain, R.N., and Rinker, A.G. (1993). Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules. Nature 363, 725-728.
23. Ghosh, P., Amaya, M., Mellins, E., and Wiley, D.C. (1995). The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378, 457-462.
24. Guerra, C.B., Busch, R., Doebele, R.C., Liu, W., Sawada, T., Kwok, W.W., Chang, M.Y., and Mellins, E.D. (1998). Novel glycosylation of HLA-DRa disrupts antigen presentation without altering endosomal localization. J. Immunol. 160, 4289-4297.
25. Jardetzky, T.S., Brown, J.H., Gorga, J.C., Stern, L.J., Urban, R.G., Chi, Y., Stauffacher, C., Strominger, J.L., and Wiley, D.C. (1994). Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368, 711-718.
26. Jones, T.A., Zou, J.-Y., Cowan, S.W., and Kjeldgaard, M. (1991). Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Cryst. A 47, 110-119.
27. Kelly, A.P., Monaco, J.J., Cho, S., and Trowsdale, J. (1991). A new human HLA class II-related locus, DM. Nature 353, 571-573.
28. Kim, J., Urban, R.G., Strominger, J.L., and Wiley, D.C. (1994). Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science 266, 1870-1874.
29. Kropshofer, H., Arndt, S.O., Moldenhauer, G., Hammerling, G.J., and Vogt, A.B. (1997). HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity 6, 293-302.
30. Liljedahl, M., Kuwana, T., Fung-Leung, W.-P., Jackson, M.R., Peterson, P.A., and Karlsson, L. (1996). HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. EMBO J. 15, 4817-4824.
31. Liljedahl, M., Winqvist, O., Surh, C.D., Wong, P., Ngo, K., Teyton, L., Peterson, P.A., Brunmark, A., Rudensky, A.Y., Fung-Leung, W.-P., et al. (1998). Altered antigen presentation in mice lacking H2-O. Immunity 8, 233-243.
32. Mellins, E., Cameron, P., Amaya, M., Goodman, S., Pious, D., Smith, L., and Arp, B. (1994). A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides. J. Exp. Med. 179, 541-549.
33. Morris, P., Shaman, J., Attaya, M., Amaya, M., Goodman, S., Bergman, C., Monaco, J.J., and Mellins, E. (1994). An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368, 551-554.
34. Park, S.-J., Sadegh-Nasseri, S., and Wiley, D.C. (1995). Invariant chain made in E. coli has an exposed N-terminal segment that blocks antigen binding to HLA-DR1 and a trimeric C-terminal that binds empty DR1. Proc. Nat. Acad. Sci. USA 92, 11289-11293.
35. Riberdy, J.M., Newcomb, J.R., Surman, M.J., Barbosa, J.A., and Cresswell, P. (1992). HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature 360, 474-477.
36. Sanderson, F., Thomas, C., Neefjes, J., and Trowsdale, J. (1996). Association between HLA-DM and HLA-DR in vivo. Immunity 4, 87-96.
37. Sette, A., Ceman, S., Kubo, R.T., Sakaguchi, K., Appella, E., Hunt, D.F., Davis, T.A., Michel, H., Shabanowitz, J., Rudersdorf, R., et al. (1992). Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science 258, 1801-1804.
38. Sherman, M.A., Weber, D.A., and Jensen, P.E. (1995). DM enhances peptide binding to class II MHC by release of invariant-chain derived peptide. Immunity 3, 197-205.
39. Sloan, V.S., Cameron, P., Porter, G., Gammon, M., Amaya, M., Mellins, E., and Zaller, D.M. (1995). Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375, 802-806.
40. Stern, L.J., and Wiley, D.C. (1992). The human class II MHC protein HLA-DR1 assembles as empty ab heterodimers in the absence of antigenic peptide. Cell 68, 465-477.
41. Stern, L.J., Brown, J.H., Jardetzky, T.S., Gorga, J.C., Urban, R.G., Strominger, J.L., and Wiley, D.C. (1994). Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368, 215-221.
42. Stryer, L. (1981). Biochemistry. (New York: W.H. Freeman), pp. 220-227.
43. Tonnelle, C., DeMars, R., and Long, E.O. (1985). DOβ: a new β chain gene in HLA-D with a distinct regulation of expression. EMBO J. 4, 2839-2847.
44. Trowsdale, J., and Kelly, A. (1985). The human HLA class II a chain gene DZα is distinct from genes in the DP, DQ and DR subregions. EMBO J. 4, 2231-2237.
45. Ullrich, H.J., Doring, K., Gruneberg, U., Jahnig, F., Trowsdale, J., and van Ham, S.M. (1997). Interaction between HLA-DM and HLA-DR involves regions that undergo conformational changes at lysosomal pH. Proc. Natl. Acad. Sci. USA 94, 13163-13168.
46. van Ham, S.M., Tjin, E.P.M., Lillemeier, B.F., Gruneberg, U., van Meijgaarden, K.E., Pastoors, L., Verwoerd, D., Tulp, A., Canas, B., Rahman, D., et al. (1997). HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading. Curr. Biol. 7, 950-957.
47. Vogt, A.B., Kropshofer, H., Moldenhauer, G., and Hammerling, G.J. (1996). Kinetic analysis of peptide loading onto HLY-Dr molecules mediated by HLA-DM. Immunology 93, 9724-9729.
48. d in lipid membranes. Proc. Natl. Acad. Sci. USA 83, 9660-9664.
49. Weber, D.A., Evavold, B.D., and Jensen, P.E. (1996). Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 274, 618-620.
50. Wei, Y., Schottel, J.L., Derewenda, U., Swenson, L., Patkar, S., and Derewenda, Z.S. (1995). A novel variant of the catalytic triad in the Streptomyces scabies esterase. Nat. Struct. Biol. 2, 218-223.
51. Wolf, P.R., and Ploegh, H.L. (1995). How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu. Rev. Cell Dev. Biol. 11, 267-306.
52. Zeng, Z.-H., Castaño, A.R., Segelke, B.W., Stura, E.A., Peterson, P.A., and Wilson, I.A. (1997). Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science 277, 339-345.